Literature DB >> 11434376

Large-scale preparation of the oligosaccharide phosphate fraction of Pichia holstii NRRL Y-2448 phosphomannan for use in the manufacture of PI-88.

V Ferro1, K Fewings, M C Palermo, C Li.   

Abstract

Mild acid-catalysed hydrolysis of the extracellular phosphomannan of the yeast Pichia holstii NRRL Y-2448 produces a high-molecular-weight phosphomannan core, a low-molecular-weight oligosaccharide phosphate fraction, and a neutral oligosaccharide fraction. A method was developed for the large-scale preparation of the oligosaccharide phosphate fraction, consisting predominantly of the pentasaccharide phosphate, 6-O-PO3H2-alpha-D-Man-(1 --> 3)-alpha-D-Man-(1 --> 3)-alpha-D-Man-(1 C 3)-alpha-D-Man-(1 --> 2)-D-Man, for use in the manufacture of the promising new anti-cancer agent, PI-88. Further insights were also gained into the structure of the phosphomannan by HPLC analysis of the time course of the hydrolysis reaction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434376     DOI: 10.1016/s0008-6215(01)00061-1

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  9 in total

Review 1.  Mechanisms of heparanase inhibitors in cancer therapy.

Authors:  Benjamin Heyman; Yiping Yang
Journal:  Exp Hematol       Date:  2016-08-26       Impact factor: 3.084

Review 2.  Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.

Authors:  Khushboo Gulati; Krishna Mohan Poluri
Journal:  Glycoconj J       Date:  2015-12-03       Impact factor: 2.916

3.  Design, synthesis, and evaluation of heparan sulfate mimicking glycopolymers for inhibiting heparanase activity.

Authors:  Ravi S Loka; Fei Yu; Eric T Sletten; Hien M Nguyen
Journal:  Chem Commun (Camb)       Date:  2017-08-10       Impact factor: 6.222

4.  Theoretical and NMR-based Conformational Analysis of Phosphodiester-linked Disaccharides.

Authors:  Alexey G Gerbst; Andrei V Nikolaev; Dmitry V Yashunsky; Alexander S Shashkov; Andrey S Dmitrenok; Nikolay E Nifantiev
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

5.  Anti-metastatic semi-synthetic sulfated maltotriose C-C linked dimers. Synthesis and characterisation.

Authors:  Elena Vismara; Alessia Coletti; Antonio Valerio; AnnaMaria Naggi; Elena Urso; Giangiacomo Torri
Journal:  Molecules       Date:  2012-08-17       Impact factor: 4.411

Review 6.  Heparin Mimetics: Their Therapeutic Potential.

Authors:  Shifaza Mohamed; Deirdre R Coombe
Journal:  Pharmaceuticals (Basel)       Date:  2017-10-02

7.  Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.

Authors:  Megan E Zavorka; Christopher M Connelly; Rosslyn Grosely; Richard G MacDonald
Journal:  Oncotarget       Date:  2016-09-20

Review 8.  Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy.

Authors:  Aikaterini Berdiaki; Monica Neagu; Eirini-Maria Giatagana; Andrey Kuskov; Aristidis M Tsatsakis; George N Tzanakakis; Dragana Nikitovic
Journal:  Biomolecules       Date:  2021-03-08

Review 9.  From Cancer to COVID-19: A Perspective on Targeting Heparan Sulfate-Protein Interactions.

Authors:  Mohit Chhabra; Gareth G Doherty; Nicholas W See; Neha S Gandhi; Vito Ferro
Journal:  Chem Rec       Date:  2021-06-19       Impact factor: 6.935

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.